GlobalData forecasts AbbVie holding strong in immunology - The Pharma Letter

GlobalData forecasts AbbVie holding strong in immunology  The Pharma Letter

A report from industry analyst GlobalData suggests that AbbVie's (NYSE: ABBV) strong immunology pipeline will protect its grip on the plaque psoriasis and ...